BlackRock Advisors’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $3K | Hold |
1,808
| – | – | ﹤0.01% | 3597 |
|
|
2016
Q3 | $6K | Hold |
1,808
| – | – | ﹤0.01% | 3563 |
|
|
2016
Q2 | $8K | Sell |
1,808
-2,999
| -62% | -$13.3K | ﹤0.01% | 3565 |
|
|
2016
Q1 | $27K | Sell |
4,807
-10,935
| -69% | -$61.4K | ﹤0.01% | 3306 |
|
|
2015
Q4 | $271K | Sell |
15,742
-6,651
| -30% | -$114K | ﹤0.01% | 2363 |
|
|
2015
Q3 | $472K | Sell |
22,393
-22,789
| -50% | -$480K | ﹤0.01% | 2200 |
|
|
2015
Q2 | $2.24M | Buy |
45,182
+29,171
| +182% | +$1.44M | ﹤0.01% | 1194 |
|
|
2015
Q1 | $1.25M | Buy |
16,011
+9,445
| +144% | +$740K | ﹤0.01% | 1406 |
|
|
2014
Q4 | $398K | Sell |
6,566
-309
| -4% | -$18.7K | ﹤0.01% | 2135 |
|
|
2014
Q3 | $293K | Buy |
6,875
+123
| +2% | +$5.24K | ﹤0.01% | 2338 |
|
|
2014
Q2 | $417K | Sell |
6,752
-635
| -9% | -$39.2K | ﹤0.01% | 2109 |
|
|
2014
Q1 | $480K | Buy |
7,387
+813
| +12% | +$52.8K | ﹤0.01% | 2046 |
|
|
2013
Q4 | $370K | Buy |
6,574
+838
| +15% | +$47.2K | ﹤0.01% | 2244 |
|
|
2013
Q3 | $352K | Buy |
5,736
+151
| +3% | +$9.27K | ﹤0.01% | 2162 |
|
|
2013
Q2 | $326K | Buy |
+5,585
| New | +$326K | ﹤0.01% | 2143 |
|